Actively Recruiting
Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Led by Shionogi · Updated on 2025-08-27
98
Participants Needed
2
Research Sites
95 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics (PK) of single- and multiple-dose administration of S-892216-LAI in healthy adults.
CONDITIONS
Official Title
Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male participants aged 18 to 55 years
- Body mass index (BMI) between 18.5 and 32.0 kg/m²
- Healthy adults without significant medical conditions that affect drug absorption, metabolism, or elimination
You will not qualify if you...
- History or presence of serious cardiovascular, respiratory, liver, kidney, gastrointestinal, endocrine, blood, neurological, or eye disorders
- History of cancer except treated basal or squamous cell skin carcinoma with no metastatic disease for 3 years
- Need for medication or other treatments such as dietary restrictions or physical therapy
- Participation in other clinical studies involving investigational drugs or medical research within 30 days or 5 times the half-life of the drug before consent
- Positive test for hepatitis B surface antigen, hepatitis C antibody, or HIV antigen/antibody within 6 months prior to study
- Positive SARS-CoV-2 test at admission for each study period
- Known allergy or sensitivity to components of S-892216-LAI or placebo
- Use of cannabis, tobacco, or nicotine products within 6 months prior to admission
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
ICON Clinical Research: Lenexa
Lenexa, Kansas, United States, 66219
Actively Recruiting
2
ICON Clinical Research: Salt Lake City
Salt Lake City, Utah, United States, 84124
Actively Recruiting
Research Team
S
Shionogi Clinical Trials Administrator Clinical Support Help Line
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here